Espec Corp.
Espec Corp. Fundamental Analysis
Espec Corp. (6859.T) shows moderate financial fundamentals with a PE ratio of 13.57, profit margin of 8.05%, and ROE of 9.55%. The company generates $67.7B in annual revenue with moderate year-over-year growth of 8.31%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 53.8/100 based on profitability, valuation, growth, and balance sheet metrics. The C grade reflects average fundamentals, with notable risks in certain areas.
Fundamental Health Score
We analyze 6859.T's fundamental strength across five key dimensions:
Efficiency Score
Weak6859.T struggles to generate sufficient returns from assets.
Valuation Score
Moderate6859.T shows balanced valuation metrics.
Growth Score
Excellent6859.T delivers strong and consistent growth momentum.
Financial Health Score
Excellent6859.T maintains a strong and stable balance sheet.
Profitability Score
Weak6859.T struggles to sustain strong margins.
Key Financial Metrics
Is 6859.T Expensive or Cheap?
P/E Ratio
6859.T trades at 13.57 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 6859.T's PEG of 42.44 indicates potential overvaluation.
Price to Book
The market values Espec Corp. at 1.25 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 9.30 times EBITDA. This is generally considered low.
How Well Does 6859.T Make Money?
Net Profit Margin
For every $100 in sales, Espec Corp. keeps $8.05 as profit after all expenses.
Operating Margin
Core operations generate 10.13 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $9.55 in profit for every $100 of shareholder equity.
ROA
Espec Corp. generates $6.88 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Espec Corp. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Espec Corp. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
6859.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
13.57
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
42.44
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.25
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.09
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.009
vs 25 benchmark
Current Ratio
Current assets to current liabilities
3.39
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.10
vs 25 benchmark
ROA
Return on assets percentage
0.07
vs 25 benchmark
ROCE
Return on capital employed
0.11
vs 25 benchmark
How 6859.T Stacks Against Its Sector Peers
| Metric | 6859.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 13.57 | 34.43 | Better (Cheaper) |
| ROE | 9.55% | 1135.00% | Weak |
| Net Margin | 8.05% | -134663.00% (disorted) | Weak |
| Debt/Equity | 0.01 | 7.92 | Strong (Low Leverage) |
| Current Ratio | 3.39 | 5.77 | Strong Liquidity |
| ROA | 6.88% | -310462.00% (disorted) | Weak |
6859.T outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Espec Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
66.03%
Industry Style: Growth, Innovation, High Beta
High GrowthEPS CAGR
123.09%
Industry Style: Growth, Innovation, High Beta
High GrowthFCF CAGR
-4.41%
Industry Style: Growth, Innovation, High Beta
Declining